← Issue №1/ week of Jun 24, 2026/IBD

ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease.

From GI Signals issue №1: what this paper found, what it changes, and where it sits against the current standard of care, reviewed by Simon Mathews, MD.

IBD guideline · Jul 7, 2026 · J of Crohn's and Colitis · IF 8.3

ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease.

Guideline / reviewguidelineCrohn's diseaseulcerative colitis
Clinical takeawayBefore or early in immunosuppressive or biologic therapy for IBD, complete an infection-prevention bundle: screen for latent TB and hepatitis B, check VZV and measles immunity, and vaccinate (recombinant zoster for immunosuppressed adults, updated pneumococcal schedule, annual influenza, COVID), avoiding live vaccines during active immunosuppression.
What it foundThe abstract does not report specific numerical results or effect sizes, as it is a guideline review.
ContextThese guidelines consolidate and update prior evidence and recommendations, providing a comprehensive approach to infection management in IBD, which is critical given the immunosuppressive therapies commonly used.
No standard claimed for this paper

Every paper is compared to the standard governing its question. This one is not: either no standard in the corpus matches it, or the comparison did not hold up on review and was withdrawn rather than published unverified. Both are logged.

Yanai H … Gisbert JP · Journal of Crohn's and Colitis · IF 8.3 · PubMed ↗Permalink
← Read the whole of issue №1 Every paper GI Signals surfaces gets a page like this one. All issues